Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • ELECTRONIC HEALTH RECORDS—C.D. Ill.: Suit against hospital over embedding tracking technology moves forward
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Physician’s challenge to CMS preclusion list placement dismissed for untimeliness
    • EXPERT INSIGHTS—FDA moves to streamline biosimilar development: The implications for regulatory and IP strategy
    • GENERAL HEALTH CARE NEWS—D. Ariz.: Swedish test manufacturer with no presence in U.S. faces Lanham Act litigation
    • MEDICAID—D. Md.: Federal court remands Medicaid payment dispute, rejects federal jurisdiction arguments
    • MEDICAL DEVICES—PROPOSED RULES: Classification of blood irradiators proposed
    • MEDICAL DEVICES—PROPOSED RULES: FDA proposes filing requirement for blood irradiator PMAs
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
    • WORTH NOTING—Other Health Law litigation and regulatory developments
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, MEDICAL DEVICES—PROPOSED RULES: Classification of blood irradiators proposed, (Mar 23, 2026)

    By WK Editorial Staff

    The proposed classification action classifies blood irradiators intended to prevent TA–GVHD into class II as well as establish the special controls necessary to provide reasonable assurance of the safety and effectiveness of these devices.

    The ...

    By WK Editorial Staff

    The proposed classification action classifies blood irradiators intended to prevent TA–GVHD into class II as well as establish the special controls necessary to provide reasonable assurance of the safety and effectiveness of these devices.

    The FDA classify blood irradiator devices, which are unclassified, preamendments devices, into two classes based on intended use. The FDA would classify blood irradiator devices (product code MOT), unclassified preamendments devices, as follows: blood irradiator devices intended to prevent transfusion-associated graftversus-host disease into class II (special controls) with premarket notification and blood irradiator devices intended to prevent metastasis into class III (premarket approval) to provide a reasonable assurance of safety and effectiveness of these devices (Proposed rule, 91 Fed. Reg. 12951 (Mar. 18, 2026)).

    Dates. Either electronic or written comments on the proposed rule must be submitted by May 18, 2026.

    FederalRegisterIssuances: ProposedRules FDCActNews MDeviceNews SafetyNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use